SH229 Tablets Combined With Daclatasvir Dihydrochloride Tablets in Treatment Adult Patients With Chronic Hepatitis C
Clinical trial NCT04070235 · UNKNOWN
Trial details
- NCT number
- NCT04070235
- Sponsor
- Nanjing Sanhome Pharmaceutical, Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-29
- Primary completion
- 2019-12-01
- Enrollment
- 440
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.